Llagas por Dentadura

Berberine, the primary alkaloid of Goldenseal, barberry, and Oregon grape, demonstrates direct antibacterial activity against uropathogens including drug-resistant E. coli in vitro. It inhibits bacterial adhesion to uroepithelial cells and disrupts biofilm formation. It is identified as the key antimicrobial compound in goldenseal for UTI, with activity against a broad spectrum of bacteria, viruses, fungi, and protozoa.

Beta-sitosterol is a phytosterol with the strongest clinical evidence among natural supplements for BPH-related lower urinary tract symptoms. A Cochrane review of 519 men found beta-sitosterol significantly improved IPSS scores and urinary flow rate compared to placebo. It reduces inflammation and relaxes smooth muscle tissue in the prostate, improving urine flow.

Sodium bicarbonate alkalinizes urine and has been used as a symptomatic agent for dysuria (painful urination) associated with cystitis-type symptoms, particularly by reducing acid irritation of inflamed bladder tissue. A 2016 Cochrane systematic review found no RCTs meeting inclusion criteria for urinary alkalisers in symptomatic uncomplicated UTI, and evidence of antibacterial efficacy is absent. Symptomatic benefit in non-bacteriuric patients has been described.

Blueberry anthocyanins have demonstrated in vitro antibacterial activity against urinary tract infection pathogens including E. coli, K. pneumoniae, and P. aeruginosa. Human clinical evidence for UTI prevention specifically from blueberry (distinct from cranberry) remains limited.

The German Commission E positively rated butterbur rhizome for adjunctive treatment of spasmodic urinary tract pain. Clinical and pharmacological evidence supports antispasmodic activity in the urinary tract via calcium channel blockade and leukotriene inhibition. Small human studies on urinary frequency have been published.

Chanca piedra (Phyllanthus niruri/amarus) is used in traditional Amazonian and South Asian medicine as a 'stone breaker' for urinary calculi. Multiple published studies including clinical trials and reviews confirm inhibition of calcium oxalate crystallization, reduction of hyperoxaluria, and promotion of urinary stone elimination. A clinical study in The Brazilian Journal of Urology demonstrated elimination of urinary stones.

Corn silk has traditional and limited clinical evidence supporting use in urinary tract infection (UTI) symptom relief, acting as a diuretic and anti-inflammatory. A clinical study by Sahib et al. demonstrated significant reduction of UTI symptoms with aqueous corn silk extract. Its bioactive compounds are proposed to soothe urinary tract tissue and inhibit bacterial growth.

Cranberry contains A-type proanthocyanidins (PACs) that inhibit the adherence of uropathogenic E. coli to urothelial cells. A 2017 meta-analysis found cranberry reduced UTI recurrence risk by 26% (pooled RR 0.74). A 2024 network meta-analysis with moderate-to-low certainty supported cranberry juice for UTI prevention. A 2025 multicenter RCT confirmed whole cranberry powder reduced culture-confirmed UTI incidence in women with recurrent UTI history.

A human RCT found that twice-daily HS and Boswellia serrata tablets for 7 days reduced UTI symptoms and recurrence comparably to antibiotics in 93 women with uncomplicated UTIs. HS extracts inhibit urease, a key enzyme in UTI-associated bacterial virulence, and exhibit antimicrobial activity against common uropathogens in vitro.

Clinical trials have studied the horseradish-nasturtium combination (Angocin Anti-Infekt N) for UTIs. A randomised double-blind placebo-controlled trial showed significantly reduced UTI recurrence (0.43 vs. 0.77 episodes, p=0.035). A prospective cohort study in 479 UTI patients found efficacy comparable to antibiotics. Evidence is for the combination product.

Hyaluronic acid is a glycosaminoglycan naturally present in the bladder glycosaminoglycan (GAG) layer, which forms a protective barrier against bacterial adhesion. Intravesical hyaluronic acid instillation is used clinically to restore GAG layer integrity and prevent recurrent UTIs. Multiple clinical studies and a 2023 PMC review confirm its role as a novel key ingredient in urinary tract health.

L. casei Shirota administration before or after initial challenge has been shown to dramatically inhibit E. coli growth in a murine model of urinary tract infection. The strain is among those studied for UTI prevention through competitive exclusion and immune modulation. Clinical human evidence specific to L. casei for UTI is limited but the preclinical data is documented in peer-reviewed literature.

Lactobacillus crispatus is a dominant native vaginal probiotic species associated with protection against urinary tract infections in women. Its presence in the vaginal microbiome is inversely correlated with UTI susceptibility. A clinical trial demonstrated intravaginal L. crispatus CTV-05 significantly reduced UTI recurrence in premenopausal women.

L. gasseri is a natural colonizer of the lower urinary tract and produces antimicrobial compounds including bacteriocins (gassericin), lactic acid, and hydrogen peroxide that can inhibit uropathogens. Clinical trials have examined oral L. gasseri for reducing UTI recurrence and supporting the urinary microbiome, particularly in women.

Lactobacillus reuteri (strain RC-14) is consistently paired with L. rhamnosus GR-1 in UTI prevention clinical trials. Multiple double-blind RCTs and meta-analyses support the L. reuteri RC-14 + L. rhamnosus GR-1 combination for reducing recurrent UTI in women. The mechanism involves competitive exclusion of uropathogens and modulation of the urogenital microbiome.

Lactobacillus rhamnosus (particularly strain GR-1) is among the most studied Lactobacillus strains for prevention of recurrent urinary tract infections. A meta-analysis and multiple RCTs support its role in reducing UTI recurrence in adult women, with one double-blind study showing significant reduction in recurrence rates compared to control. The mechanism involves vaginal and urogenital colonization, preventing pathogen adhesion.

Lemon juice increases urine volume and citrate levels, two key factors in preventing urinary stone disease and maintaining urinary tract health. Clinical studies confirm that lemonade therapy increases urinary output by up to 860 mL/day, supporting urinary dilution and reducing stone recurrence risk.

Pharmacological studies confirm diuretic activity of L. gracile extracts, consistent with its traditional use for urinary discomfort and inflammation. Antibacterial activity against UTI-relevant organisms (E. coli, Staphylococcus aureus) has been demonstrated in vitro. The Chinese Pharmacopoeia lists painful urination among its indications. Evidence remains preclinical.

D-mannose (mannose) is a monosaccharide that inhibits uropathogenic E. coli from adhering to urothelial cells by binding to bacterial FimH adhesins. Multiple RCTs and systematic reviews support its efficacy for prevention of recurrent UTIs, with one 2014 RCT showing comparable effectiveness to nitrofurantoin prophylaxis. A 2025 systematic review and meta-analysis confirmed prophylactic benefits.

Methenamine is an established urinary tract antiseptic first introduced in 1895 and used continuously since as a non-antibiotic option for suppressing and preventing recurrent urinary tract infections. Multiple systematic reviews and RCTs document its efficacy in adults, particularly women with anatomically normal urinary tracts. It reduces symptomatic UTI episodes and bacteriuria in patients without structural urinary abnormalities.

N-acetyl cysteine (NAC) is a thiol antioxidant with established anti-biofilm and antibacterial activity relevant to urinary tract infections. In vitro studies demonstrate NAC prevents E. coli and E. faecalis invasion of bladder epithelial cells, inhibits biofilm formation, and acts as a potent urease inhibitor preventing catheter encrustation in catheter-associated UTIs. Clinical studies in adults have demonstrated NAC prevents UTIs and enhances antibiotic effectiveness.

In vitro studies confirm that neem leaf ethanolic extract has antibacterial activity against principal uropathogens including E. coli, P. aeruginosa, S. aureus, Klebsiella pneumoniae, and ESBL-producing organisms. Neem seed oil has documented diuretic properties. Human clinical trials for UTI treatment with neem are absent; evidence is in vitro.

C. rotundus is documented as anti-uropathogenic in pharmacological reviews. It inhibits urinary tract pathogen adhesion and growth in vitro. A ScienceDirect paper specifically identifies it as 'a potential novel source of therapeutic compound against urinary tract pathogens.' Traditional use for cystitis is also reported.

Phyllanthus (Phyllanthus niruri/amarus, 'chanca piedra') is well-documented for anti-urolithiatic (stone-breaking) and UTI-related activity. Multiple studies confirm it inhibits calcium oxalate crystallization, reduces hyperoxaluria, and promotes urinary stone elimination. Clinical evidence includes studies showing effectiveness in urinary stone elimination.

P. umbellatus is a primary diuretic herb in TCM with well-characterized pharmacological mechanisms. Ergone, ergosterol, and D-mannitol have been identified as active diuretic compounds, and in vivo studies confirm significant increases in urine volume and electrolyte excretion.

Prunus africana bark extract has documented clinical effects on lower urinary tract symptoms through its anti-inflammatory and anti-androgen mechanisms, with broad endorsement from the EMA and ESCOP for urinary complaints associated with BPH. Traditional African medicine also used the bark for general urinary problems independently of prostate pathology.

Pumpkin seed (Cucurbita pepo) is officially monographed by the German Commission E and ESCOP for irritable bladder symptoms and micturition problems in BPH stages 1 and 2. A meta-analysis of two randomized placebo-controlled 12-month trials showed pumpkin seed extract significantly improved lower urinary tract symptoms (LUTS). A Korean RCT confirmed improvements in IPSS scores compared to placebo in men with BPH.

Punarnava has deep Ayurvedic roots as a urinary purifier ('mutra vishodhana') and has been studied in animal models and some clinical settings for urinary tract support. Its diuretic action promotes flushing of the urinary tract, and antimicrobial properties against common uropathogens have been demonstrated in vitro. It is a central ingredient in classical formulations like Punarnavadi Kwath for renal and urinary health.

Pygeum africanum bark extract has been studied for lower urinary tract symptoms (LUTS) in BPH in multiple RCTs. A meta-analysis of 18 controlled trials found men taking Pygeum were more than twice as likely to report improvement in BPH symptoms compared to placebo. It has been used in Europe for decades as a phytomedicine for urinary symptoms in men with BPH.

Quercetin is a flavonoid with anti-inflammatory, anti-biofilm, and antimicrobial activities relevant to urinary tract health. It is used clinically for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), where a randomized double-blind trial showed significant symptom score improvement. It is also studied in combination with other compounds for recurrent UTI prevention.

Radish aqueous extract demonstrated significant diuretic and natriuretic effects in Wistar rat models at doses of 100–400 mg/kg, supporting its traditional use in Ayurveda and folk medicine for urinary conditions. The diuretic effect is attributed to flavonoids, glycosides, and essential oils promoting renal vasodilation. No human diuretic trials have been published.

Saw palmetto (Serenoa repens) berry extract is the most extensively studied phytotherapy for lower urinary tract symptoms (LUTS) in men with BPH. An early Cochrane review of 18 RCTs (n=2939) found significant improvement in urinary flow and symptom scores. More recent Cochrane analysis and meta-analyses show mixed results with high-quality extracts, and EMA has granted well-established use status for hexanic saw palmetto extract for BPH-related LUTS.

Aster tataricus is documented in both TCM clinical records and preclinical pharmacology for urinary conditions. The herb exerts diuretic effects confirmed in clinical TCM use and has been studied mechanistically for interstitial cystitis protection via NLRP3 pathway suppression in animal and cell models.

T. cordifolia has been clinically investigated for urinary infections and has documented antibacterial activity against urinary tract pathogens. It is traditionally used in Ayurveda for urinary diseases, gonorrhea, and dysuria. Its diuretic and antimicrobial properties underpin this use.

TCM uses adzuki bean (Chi Xiao Dou) to clear heat and promote urination, making it a traditional remedy for urinary discomfort, difficulty urinating, and urinary tract inflammatory conditions. It is listed in the Chinese Pharmacopoeia for these indications. Scientific clinical evidence for urinary tract infection treatment or urinary health improvement is absent.

Aerva lanata is used in Ayurvedic and traditional South Asian medicine as a diuretic and anti-urolithiatic herb for urinary stones and urinary tract inflammation. It is included in Cystone, a clinically studied polyherbal Ayurvedic formulation for urinary calculi. In vitro and animal studies support anti-urolithiatic and diuretic activities.

Agrimony has well-documented traditional use across multiple European folk medicine traditions for urinary tract conditions, including cystitis, pyelonephritis, and general urinary tract infections. The EMA notes diuretic and urinary tonic properties. It is an ingredient in official preparations for urinary health in several EU countries.

Alfalfa has documented traditional use for urinary tract disorders including cystitis, with diuretic properties cited across Ayurvedic, early American, and folk herbal traditions. RxList and Drugs.com monographs confirm urinary tract as a traditional indication. Human clinical evidence is absent.

Amber (Hu Po) is a classical TCM diuretic, used for difficult or painful urination, urinary retention, and bloody urine. It enters the Bladder channel in TCM and promotes urination to relieve what is called 'lin syndrome.' No human clinical trials specifically for UTI using amber alone exist.

Traditional use of Andrographis for lower urinary tract infections and urinary health is documented in TCM, Ayurveda, and Southeast Asian traditional medicine. It is listed among classical TCM indications for 'toxic heat' affecting the kidneys and urinary tract. No human RCTs specifically for UTI have been identified.

Anemarrhena is classified as diuretic in traditional pharmacopeias and has documented use for urinary tract infections (stranguria, cystitis, turbid urine) in TCM. It is included in classical formulas for urinary conditions, particularly where heat and Yin deficiency are present.

Annatto seeds are documented as having diuretic properties and have been used in Peruvian traditional medicine for cystitis and urinary tract conditions. Leaf decoctions are used for gonorrhea, urinary infections, and prostate disorders. Human clinical evidence is absent.

Arbutin is the principal active glycoside in bearberry leaf, hydrolyzed in the body to hydroquinone which exerts urinary antiseptic activity. Its use for UTIs dates to at least the 18th–19th centuries in European herbal medicine. Bearberry and arbutin-containing products are included in several pharmacopeias for urinary complaints. Modern guidelines consider this traditional use plausible but lacking robust clinical proof.

Asparagus has one of the most historically consistent traditional uses as a diuretic for urinary tract health, documented across ancient Greek, Roman, Chinese, Persian, and Ayurvedic medicine. It is listed in the pharmacopoeias of France, Mexico, Portugal, and Venezuela for urinary tract indications. Modern studies confirm a diuretic effect attributed to asparagine. Human RCT evidence for UTI or urinary tract inflammation specifically is lacking.

Barberry has traditional use as an antimicrobial for urinary tract infections and bladder health, documented across European and Ayurvedic herbal traditions. Its berberine content provides broad-spectrum antimicrobial activity against common uropathogens, though clinical RCT evidence is limited.

Bearberry (Arctostaphylos uva-ursi) has been used since at least the 2nd century for urinary tract complaints and was listed in the US Pharmacopeia as a urinary antiseptic from 1820–1936. The active compound arbutin is hydrolyzed to hydroquinone in alkaline urine, exerting mild antiseptic effects. The European Medicines Agency (EMA/HMPC) classifies it as a traditional herbal medicinal product for mild recurrent lower UTI symptoms in women. Clinical trial evidence remains limited and of low quality.

Birch leaf holds traditional use classification from the EMA HMPC and ESCOP for urinary tract irrigation including minor infections and renal gravel. The diuretic and antiadhesive properties of birch leaf constituents support its traditional role. A clinical pilot study in 15 UTI patients suggested benefit, but data were insufficient for well-established medicinal use classification.

Boerhavia diffusa (punarnava) is a classical Ayurvedic herb classified as Mutrala (diuretic) and Shothahara (anti-inflammatory), used for centuries for urinary tract infections, kidney stones, fluid retention, and kidney support. Traditional Ayurvedic texts prescribe it for mutrakrichra (difficult urination) and ashmari (urinary calculi). Animal studies support diuretic, anti-inflammatory, and nephroprotective effects; high-quality human clinical trials are limited.

Borage leaves and flowers have a well-documented traditional use as a diuretic for urinary tract conditions including cystitis and kidney inflammation. Leaf infusions were traditionally taken to induce urination. No clinical trials have evaluated borage specifically for UTI outcomes.

Buchu (Agathosma betulina and A. crenulata), native to South Africa, has long been used traditionally as a urinary antiseptic and diuretic. Its leaves contain diosphenol and other essential oils with antimicrobial and anti-inflammatory activity. Buchu is included in Western herbal reviews for urinary tract infections. Clinical evidence in humans is very limited; use is based primarily on traditional practice and in vitro data.

The EMA community herbal monograph formally recognizes burdock root as a traditional herbal medicine to increase urine output, helping to eliminate microbes and metabolic waste during minor urinary tract infections. This diuretic-flushing mechanism has been used in European phytotherapy for centuries. A 2017 preclinical study showed burdock extract limited biofilm formation by major urinary tract pathogens.

Butcher's broom has a long, well-documented history of traditional use as a mild diuretic and for urinary conditions across European and Mediterranean folk medicine. ESCOP and EMEA recognize this use. No clinical trials have specifically evaluated its effects on urinary tract health.

Cardamom is used in Ayurvedic and traditional South Asian medicine for urinary tract infections, dysuria, and urinary clearance, primarily through its diuretic properties. Antimicrobial properties against urinary pathogens provide mechanistic support. No human clinical trials specifically addressing urinary tract health for cardamom have been published.

Wild and cultivated carrot have been used in traditional medicine systems for cystitis and urinary tract health, attributed to diuretic, antiseptic, and antilithic properties of carrot seed and root constituents. No human clinical trials specifically confirm these effects.

The Ashaninka indigenous tribe of Peru used cat's claw specifically for 'inflammations of the urinary tract,' making this one of the best-documented traditional indications. A 2025 PMC ethnopharmacology review and several ethnobotanical databases list urinary tract inflammation among its traditional uses. No clinical trials have been conducted.

Celery fruits have documented use in traditional Persian, European, and Ayurvedic medicine for uncomplicated urinary tract infections, attributed to diuretic and anti-inflammatory activity. The European Medicines Agency (2012) recognized this traditional use. Preclinical work identified anti-adhesive phthalides against uropathogenic E. coli.

A. aspera has been used in Ayurveda and across multiple traditional systems for urinary disorders, urinary calculi, dropsy, and gonorrhea. It has documented diuretic activity in animal models, providing limited scientific support.

Chickweed is documented in herbal traditions as a soothing diuretic for cystitis and irritable bladder, reducing urinary tract inflammation and supporting urinary elimination. Multiple herbal monographs consistently report this use. No clinical trials have been performed.

Urinary tract support is cleavers' most consistently documented traditional application, across European, Native American, and Asian traditions. It was used for UTIs, painful urination, and urinary inflammation. Preclinical diuretic evidence exists; no human RCTs have been published.

Clematis armandii and C. montana ('Chuan Mu Tong') are recorded in the Chinese Pharmacopoeia specifically for clearing damp-heat from the bladder and promoting urination in painful or dribbling urinary conditions. This is a well-documented traditional indication in TCM spanning centuries, though no clinical evidence supports it independently.

Promoting urination and draining dampness is the foremost traditional action of coix seed in TCM, used for edema, difficult urination, and urinary obstruction. This is documented in multiple authoritative Chinese herbal references and pharmacopeias.

Coleus forskohlii has been used in Ayurveda to treat painful urination, bladder pain, and urinary infections. Preclinical animal data show forskolin reduced uropathogenic E. coli in infected mice. No human clinical trials for urinary tract conditions have been completed.

Cornsilk (Stigma maydis, the silky threads of Zea mays) has been used in traditional North American and European herbal medicine as a diuretic and demulcent for urinary tract complaints including cystitis and urethritis. It is reviewed in Western herbal UTI literature alongside bearberry and cranberry. Pharmacological evidence confirms mild diuretic and anti-inflammatory properties. Clinical human trial evidence is lacking.

Couch grass (Agropyron/Elymus repens) is a traditional European and North American herbal diuretic used for urinary tract infections, cystitis, and urethritis. It is reviewed in Western herbal UTI literature alongside bearberry and goldenrod. German Commission E issued a positive monograph for couch grass for irrigation therapy in inflammatory diseases of the urinary tract. Clinical human trial evidence beyond traditional documentation is limited.

Cucumber has been used in Ayurvedic medicine (Mutrala — promotes easy urination) and various traditional systems as a diuretic to support urinary tract cleansing. Its high water content and potassium are the proposed physiological basis. Traditional use for urinary complaints is well-documented across multiple ethnomedicine systems.

Damiana is traditionally documented as a urinary antiseptic and diuretic used for bladder and kidney infections. The Atlas de las Plantas de la Medicina Tradicional Mexicana lists it for these conditions. Arbutin content provides pharmacological plausibility for urinary antiseptic activity.

Dandelion (Taraxacum officinale) has been used in European and North American herbal traditions as a diuretic to flush the urinary tract. The EMA's HMPC includes dandelion leaf in traditional diuretic herbal tea combinations for minor urinary tract complaints. In vitro and preclinical studies support its diuretic activity. One preliminary study combined with bearberry showed prevention of recurrent UTIs.

Didymocarpus (Didymocarpus pedicellata) is a key ingredient in the Ayurvedic polyherbal formulation Cystone, used clinically for kidney stones and urinary tract disorders. Traditional texts and ethnobotanical surveys describe its use for urinary calculi, urinary inflammation, and diuretic support. Scientific validation comes primarily from in vitro, animal, and combination product studies; standalone human RCT data are absent.

Dodder is used in TCM for urinary tract conditions including frequent urination and urinary incontinence, classified under 'kidney-yang deficiency' patterns. It is explicitly listed in traditional use for urinary tract disorders. In European folk medicine, it was used as a mild diuretic. Preclinical data showing improved renal tubular function provide partial mechanistic support.

Dog Rose has a documented traditional role as a urinary tract tonic and mild diuretic across European herbal medicine. Its high organic acid content, antibacterial phenolic compounds, and diuretic action support traditional use for urinary health, UTI support, and kidney function. Laboratory evidence shows antibacterial activity of rosehip polyphenols against E. coli strains responsible for UTIs.

Echinacea purpurea is widely used in traditional and modern herbal medicine as an immune stimulant with antibacterial and anti-inflammatory activity relevant to urinary tract infections. It is reviewed in Western herbal UTI literature alongside bearberry and cranberry. NCCIH acknowledges its immunomodulatory activity. Clinical evidence for UTI specifically is limited.

Flaxseed has documented traditional use for urinary tract conditions, including urinary tract infection and related complaints. A 2023 European Journal of Medical Research review confirms traditional use of linseed for urinary tract infection historically.

C. forskohlii is listed in Ayurvedic texts for urinary tract conditions including painful urination and urinary tract infections. Smooth muscle relaxation in the urinary tract is the proposed mechanism. No clinical trials for UTI or urinary tract health have been published.

Fu Ling has been used for over 2,500 years in TCM for urinary retention, oliguria, and urinary infections, documented in the Chinese Pharmacopoeia for 'edema and oliguria.' Classical formulas such as Wu Ling San address fluid retention and urinary dysfunction. Diuretic effects have been confirmed in animal studies but not human clinical trials.

Geranium is documented as a diuretic and antimicrobial agent with traditional use for urinary tract infections and kidney-related conditions. Herbal sources list UTI support as a recognized indication. No clinical trial has been conducted.

Goldenrod (Solidago virgaurea) is monographed by the EMA HMPC and ESCOP for irrigation therapy of the urinary tract in bacterial and inflammatory conditions, and is approved as a traditional herbal medicinal product in Europe. It is a constituent of the approved European herbal product Aqualibra, studied in a large noninterventional study of 1904 patients with lower uncomplicated UTI. Evidence supporting its inclusion is primarily traditional use plus pharmacological data including diuretic, anti-inflammatory, antibacterial, and spasmolytic activities.

Goldenseal (Hydrastis canadensis) has been used by Native Americans and in North American herbal tradition for urinary tract infections. Its primary active alkaloid berberine demonstrates direct antibacterial activity against E. coli and other uropathogens in vitro and inhibits bacterial adhesion to the urinary tract. Traditional use is well-documented; robust human clinical trial evidence specifically for UTI is absent.

Gravel root's primary and best-documented traditional application is to the urinary tract, addressing gravel, stones, infection, painful urination, and inflammatory conditions of the urethra, bladder, and kidneys. It is listed in the British Herbal Pharmacopoeia for these uses.

Horsetail (Equisetum arvense) has been used in European herbal medicine since the 16th century for diseases of the urinary organs. The EMA HMPC monograph classifies it as a traditional herbal medicinal product for irrigation of the urinary tract. It is also included in EMA-approved diuretic herbal tea combinations for minor urinary tract complaints. Evidence is based on long-standing traditional use and pharmacological plausibility, with limited clinical trial data.

Huckleberry leaf tea has a documented traditional use as a diuretic and urinary tract antiseptic across multiple ethnobotanical sources and 19th-century herbal literature. Folk use described the leaf decoction as helpful for urinary tract infections, attributed to quinic acid, arbutin, and tannins with antiseptic and diuretic properties. Clinical evidence for UTI prevention exists for cranberry (V. macrocarpon) but has not been specifically demonstrated for huckleberry.

Hydrangea root is one of the most historically documented herbs for urinary tract support in North American folk medicine and among Indigenous peoples. It has been used for UTIs, kidney stones, bladder infections, and painful urination. Its purported diuretic action forms the mechanistic basis. No controlled human trials support efficacy.

Hyssop is recorded as a diuretic herb in classical Western and Turkish herbalism, with traditional use for cystitis. Its diuretic and antimicrobial properties provide a plausible basis for urinary tract support.

H. indicus is documented in Ayurveda, Siddha, and Unani medicine as a treatment for urinary tract disorders, classified as diuretic and demulcent. Bactericidal activity against uropathogenic bacteria has been demonstrated in preclinical studies. No clinical trials in human UTI patients exist.

Java tea (Orthosiphon stamineus/aristatus) is officially monographed by the EMA HMPC and ESCOP as a traditional herbal medicine for irrigation therapy of the lower urinary tract, including bacterial and inflammatory conditions. It is listed in the Dutch and French Pharmacopeias and is a component of the approved European herbal product Aqualibra. Pharmacological data confirm diuretic, anti-inflammatory, antibacterial, and anti-adhesive activity against uropathogenic E. coli.

Juniper berries (Juniperus communis) are included in the EMA HMPC-approved traditional diuretic herbal tea combinations for minor urinary tract complaints, classified on the basis of long-standing use for increasing urine production and flushing the urinary tract. Juniper is also identified in Western herbal UTI reviews alongside bearberry and goldenrod. Evidence is based on traditional use; the EMA does not recommend juniper for urinary irrigation due to potential kidney irritation with long-term use.

Kava has a well-documented traditional use in Pacific Island and Western herbal medicine for urogenital conditions including dysuria, cystitis, urethritis, and overactive bladder, attributed to its diuretic, antispasmodic, and local analgesic properties. It appears in the British Herbal Pharmacopoeia as specific for genitourinary tract infections. Clinical trial evidence is absent.

Traditional medicine records from nearly 200 years ago document mangosteen peel decoctions being used to treat genitourinary disorders including cystitis and urinary tract infections. Bark concentrates were used for GU disorders including gonorrhea. No human clinical trials support this use.

Marshmallow (Althaea officinalis) root is a traditional European demulcent herb used for soothing irritated urinary mucosa in cystitis and urethritis. German Commission E and Western herbal reviews include it for irrigation therapy in inflammatory conditions of the urinary tract. Its high mucilage content forms a protective film over urothelial surfaces, reducing irritation. Clinical trial evidence in humans for UTI is absent; use is based on traditional practice and pharmacological plausibility.

TC is documented as a diuretic and urinary tract remedy in Ayurveda, Siddha, and folk medicine, with traditional use for urinary discharge, UTI, and bladder disease. Antibacterial activity against uropathogenic E. coli provides mechanistic support.

Nettle (Urtica dioica, U. urens) leaf is included by the EMA HMPC in approved traditional diuretic herbal tea combinations for minor urinary tract complaints. The herb is used to increase urine production and flush the urinary tract. Root preparations are also studied for lower urinary tract symptoms related to benign prostatic hyperplasia (BPH). Evidence for the leaf is traditional; for the root there is preliminary clinical trial data for BPH-related urinary symptoms.

Parsley has been used since antiquity as a urinary antiseptic and diuretic to treat urinary tract infections, supported by documented traditional use across Greek, Roman, Egyptian, and folk medicine traditions. Its diuretic action and antimicrobial volatile oils (apiol, myristicin) underlie this use. Controlled human UTI trials are absent.

Pennycress is documented as a diuretic in European herbal traditions and was used for urine retention and urinary tract discomfort. Culpeper and 16th-century German herbals describe its diuretic and anti-inflammatory applications relevant to urinary complaints. No clinical trials have evaluated this use.

P. amurense (Huang Bai) is one of the primary TCM herbs for urinary tract conditions, specifically indicated for 'painful and difficult urination due to heat strangury' in the traditional Chinese Pharmacopoeia. TCM uses it for urinary tract infections, burning urination, and reddish urine. Berberine has antimicrobial activity against common uropathogens including E. coli.

Plantago species have traditional use as diuretics and mild anti-inflammatory agents for urinary tract complaints across European, Asian, and American folk medicine. P. asiatica is used in TCM for urinary complaints. P. major's diuretic property is documented in ethnobotanical records. No RCT data for UTI specifically exist.

Plantago major has a long tradition of use as a diuretic and for urinary tract complaints including cystitis across European, Asian, and Vietnamese traditional medicine. Preclinical diuretic effects have been studied. Traditional Chinese and Vietnamese medicine use Plantago species specifically for urinary tract inflammation.

Purslane is traditionally used as a diuretic and for urogenital infections across European, Asian, and Middle Eastern medicine. Its potassium content (494 mg/100 g) and alkaloid-driven diuretic properties are pharmacologically plausible. Multiple ethnobotanical studies document its use for urinary tract inflammation and infections. No clinical RCTs for UTI outcomes were found.

Queen of the meadow is classified in the British Herbal Pharmacopoeia as a mild urinary antiseptic and has been traditionally used for urinary tract inflammation, cystitis, and urethritis. The ESCOP monograph supports its traditional use in increasing water excretion. Pre-clinical antimicrobial and anti-inflammatory evidence supports plausibility.

Native American women traditionally used red root for urinary tract infections, and urinary complaints appear in Clarke's homeopathic materia medica and homeopathic clinical literature. A mild diuretic action is attributed to its alkaloid content. No modern clinical UTI trials have been conducted.

Rose oil from Rosa damascena is used in Persian medicine for infectious diseases of the genitourinary tract. Rosehip's high vitamin C content acidifies urine, creating conditions unfavorable for uropathogens. In vitro studies show antimicrobial activity of rose extracts against E. coli and other uropathogens, but human clinical trials for UTIs are absent.

Rose hip has extensively documented traditional use as a urinary tract tonic and mild diuretic across European and German folk medicine, attributed to its organic acid content, antibacterial polyphenols, and mucilaginous properties that soothe urinary mucosa. Herbal monographs and traditional medicine sources consistently list kidney and urinary tract support as a primary rose hip application.

R. cordifolia has documented traditional use for urinary tract disorders in multiple medical systems including Philippine, Unani, and Ayurvedic medicine. Its root decoction is used to treat urinary disorders, and it is classified as 'Meha' (urinary tract disorders) in Ayurveda. Preclinical evidence confirms diuretic and anti-urolithiasis properties.

Sheep's sorrel is documented across multiple traditional herbal systems as a diuretic and remedy for urinary tract complaints. Fresh leaf juice was specifically recommended for urinary and kidney diseases in folk practice. No clinical evidence supports these uses.

Shepherd's purse is documented in multiple traditional systems for urinary tract infections, hematuria, cystitis, and urinary gravel. Its combination of diuretic, astringent, antimicrobial, and hemostatic actions makes it a traditional urinary herb. The King's American Dispensatory and multiple pharmacopoeial sources specifically endorse it for urinary and renal ailments.

TCM prescribes S. baicalensis for urinary tract infections and painful urinary dysfunction. Encyclopedia.com lists 'urinary tract infections' and 'gout' (urate deposition in urinary and joint systems) among TCM indications. Native Americans also used skullcap for urinary conditions. No clinical trial evidence exists.

Slippery elm was used in Native American traditional medicine for urinary tract disorders. Its mucilage is proposed to soothe inflamed urinary tract mucosa. No clinical trials support this use, and it is not recognized in modern evidence-based urology.

Slippery elm has a well-documented traditional use for urinary tract inflammation and irritation in Native American medicine. The NIH LiverTox monograph explicitly states it was used for urinary tract disorders. No controlled human trials for urinary indications exist.

Snapdragon has been traditionally employed as a diuretic in multiple folk medicine traditions, with the whole-plant decoction used to promote urinary flow. This use is documented across European, Iraqi, and Asian ethnobotanical records. No clinical trials have evaluated this application.

White spruce cone infusions were used by Native North American tribes for urinary troubles. Spruce resin was considered diuretic and used for urinary complaints in Alaskan and other Indigenous traditions. The resin and needle oil of Picea abies were historically listed as diuretics in official materia medica.

Squawvine's use as a diuretic by the Cherokee and Iroquois and its mild anti-inflammatory properties have generated a traditional application for urinary tract conditions including UTIs and interstitial cystitis. Multiple herbal sources document this use. No clinical trials exist.

Tribulus (Gokshura) has extensive traditional use in Ayurveda, TCM, and Arabic medicine for urinary tract infections, dysuria, and urinary flow support. The plant's antimicrobial and diuretic compounds have been characterized, and these phytochemicals reinforce traditional UTI-related uses.

Tribulus terrestris (gokshura) is used in Ayurvedic medicine as a diuretic and for urinary stones (urolithiasis). In vitro and in vivo animal studies confirm antiurolithic, antioxidant, and diuretic activities. It is included in several polyherbal Ayurvedic formulations (e.g., Cystone, Uriflow) used clinically for urinary stones. Human clinical trial evidence for isolated Tribulus is limited.

Varuna (Crataeva nurvala) is a classical Ayurvedic herb specifically recommended for urinary problems including kidney and bladder stones, difficult urination (mutrakrichra), and BPH. It has litholytic, antiseptic, and anti-inflammatory actions attributed to lupeol, varunol, and flavonoids. Some clinical data exist from combination product studies; standalone human RCTs are absent.

Watermelon has documented traditional use in multiple cultures as a natural diuretic for supporting urinary tract health, flushing the bladder, and relieving urinary discomfort. Its high water content promotes urinary output. Evidence from rigorous human clinical trials is limited.

White oak bark has traditional use as a diuretic and antiseptic for urinary tract conditions including bladder infections. Its antimicrobial tannins may reduce bacterial load in the urinary tract. No clinical evidence from controlled human trials exists.

Wood betony has documented traditional use for urinary tract inflammation and urinary tract infections in European folk herbalism, attributed to its diuretic and antimicrobial properties. PeaceHealth records this use explicitly.

Yarrow is traditionally used as a diuretic and for urinary complaints in Persian and European folk medicine. Published pharmacological reviews document diuretic activity in animal models, and chitosan nanoparticles of A. millefolium have been proposed for targeted delivery in urolithiasis.

Treatment of urinary tract infections is one of the primary traditional indications for Zanthoxylum species documented in the Chinese Pharmacopoeia and African ethnobotanical records. Z. zanthoxyloides is used in Nigeria for urinary tract and venereal diseases. Antimicrobial properties provide mechanistic plausibility.